These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Metrifonate: update on a new antidementia agent. Ringman JM; Cummings JL J Clin Psychiatry; 1999 Nov; 60(11):776-82. PubMed ID: 10584768 [TBL] [Abstract][Full Text] [Related]
5. Metrifonate for Alzheimer's disease: is the next cholinesterase inhibitor better? Sandson TA Neurology; 1999 Feb; 52(3):675-6. PubMed ID: 10025821 [No Abstract] [Full Text] [Related]
6. Metrifonate for Alzheimer's disease: is the next cholinesterase inhibitor better? Knopman DS Neurology; 1998 May; 50(5):1203-5. PubMed ID: 9595961 [No Abstract] [Full Text] [Related]
7. The effects of long-term treatment with metrifonate, a cholinesterase inhibitor, on cholinergic activity, amyloid pathology, and cognitive function in APP and PS1 doubly transgenic mice. Liu L; Ikonen S; Heikkinen T; Tapiola T; van Groen T; Tanila H Exp Neurol; 2002 Feb; 173(2):196-204. PubMed ID: 11822883 [TBL] [Abstract][Full Text] [Related]
8. Metrifonate. A viewpoint. Taylor P Drugs Aging; 1997 Dec; 11(6):497. PubMed ID: 9413708 [No Abstract] [Full Text] [Related]
14. Beyond the cholinergic hypothesis: the effect of metrifonate and other cholinesterase inhibitors on neuropsychiatric symptoms in Alzheimer's disease. Kaufer D Dement Geriatr Cogn Disord; 1998; 9 Suppl 2():8-14. PubMed ID: 9718229 [TBL] [Abstract][Full Text] [Related]
15. The pharmacological basis for metrifonate's favourable tolerability in the treatment of Alzheimer's disease. Schmidt BH; Heinig R Dement Geriatr Cogn Disord; 1998; 9 Suppl 2():15-9. PubMed ID: 9718230 [TBL] [Abstract][Full Text] [Related]
16. The recovery of cerebrospinal fluid acetylcholinesterase activity in Alzheimer's disease patients after treatment with metrifonate. Unni L; Vicari S; Moriearty P; Schaefer F; Becker R Methods Find Exp Clin Pharmacol; 2000; 22(1):57-61. PubMed ID: 10791297 [TBL] [Abstract][Full Text] [Related]
17. Effects of metrifonate on cognitive decline in Alzheimer disease: a double-blind, placebo-controlled, 6-month study. Becker RE; Colliver JA; Markwell SJ; Moriearty PL; Unni LK; Vicari S Alzheimer Dis Assoc Disord; 1998 Mar; 12(1):54-7. PubMed ID: 9539412 [TBL] [Abstract][Full Text] [Related]
18. Metrifonate: a new agent for the treatment of Alzheimer's disease. Williams BR Am J Health Syst Pharm; 1999 Mar; 56(5):427-32. PubMed ID: 10096702 [TBL] [Abstract][Full Text] [Related]